Risk Model Development and Validation in Clinical Oncology: Lessons Learned

Gary H. Lyman, Pavlos Msaouel, Nicole M. Kuderer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Reliable risk models can greatly facilitate patient-centered inferences and decisions. Herein we summarize key considerations related to risk modeling in clinical oncology. Often overlooked challenges include data quality, missing data, effective sample size estimation, and selecting the variables to be included in the risk model. The stability and quality of the model should be carefully interrogated with particular emphasis on rigorous internal validation.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalCancer Investigation
Volume41
Issue number1
DOIs
StatePublished - 2023

Keywords

  • prognostic models
  • prognostic nomograms
  • Risk models

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Risk Model Development and Validation in Clinical Oncology: Lessons Learned'. Together they form a unique fingerprint.

Cite this